Abstract:Seaweeds are considered a surplus resource of a few distinct metabolic compounds with multiple health advantages, their major involvement in food and commercial supplies. The protective efficacy of algal metabolites against oxidative stress, neuroinflammation, mitochondrial dysfunction, and impaired proteostasis is supported by their pharmacological properties, which include antioxidant, anti-proliferation, and antimicrobial effects. In this study, the amounts of phytochemical elements, as well as the antiproliferation and antimicrobial efficiencies of various extracts of marine green seaweed Codium decorticatum , brown seaweed Dityota dichotoma , and red seaweed Amphiroa fragilissima , were assessed. The PC12 cell line of MTT test and cell cycle analysis were employed in the cytotoxicity research, while GC-MS and FT-IR analyses were utilized to detect phytocompounds and bioactive groups. The anti-bacterial activity, Minimum Inhibitory Concentrations, and minimal bactericidal/fungicidal concentrations against four positive pathogenic bacteria and two fungi were ascertained using the agar well-diffusion and micro-dilution methods. A. fragilissima seaweed extract in methanolic form has demonstrated greatest antimicrobial activity against the pathogens under investigation. The MBC/MFC ranges are from 0.38 μg/mL to 12.5 μg/mL and the MIC varied from 0.19 μg/mL to 6.08 μg/mL. Phyto-chemical examination showed the occurrence of saponins, flavonoids, alkaloids, steroids, phenolics, tannins, terpenes, and cardiac glycosides in given samples of the examined seaweed extracts. The only A. fragilissima extract that included flavonoids, tannins, phenolics, and glycosides was the methanolic extract. In GC-MS, the A. fragilissima seaweed extract in methanol showed 10 major peaks. A significant cytotoxicity, as evidenced by an IC 50 cell viability of 49.97% at the lowest dosage of 31.2 μg/mL. The anti-neuronal and antimicrobial activity of A. fragilissima methanolic seaweed extract was superior to those of other extracts and even conventional drugs. The results indicate that further investigation into this seaweed could be able to reveal biological molecules that are active for the future growth of the biomedical sector.

Seaweed-Derived Proteins and Peptides: Promising Marine Bioactives

Green Seaweeds as a Potential Source of Biomolecules and Bioactive Peptides: Recent Progress and Applications – A Review

Bioactive peptides and carbohydrates from seaweed for food applications: Natural occurrence, isolation, purification, and identification

Bioactive Polysaccharides from Seaweeds

Bioactive Peptides Derived from Seaweed Protein and Their Health Benefits: Antihypertensive, Antioxidant, and Antidiabetic Properties.

Applying Seaweed Compounds in Cosmetics, Cosmeceuticals and Nutricosmetics

Bioactive Peptides from Algae: Traditional and Novel Generation Strategies, Structure-Function Relationships, and Bioinformatics as Predictive Tools for Bioactivity

Seaweed-Based Molecules and Their Potential Biological Activities: An Eco-Sustainable Cosmetics

Harnessing the power of seaweed: unveiling the potential of marine algae in drug discovery

Seaweed polysaccharides: Emerging extraction technologies, chemical modifications and bioactive properties

Biological properties and potential of compounds extracted from red seaweeds

Seaweed Proteins: A Step towards Sustainability?

Marine Algae-Derived Bioactive Peptides for Human Nutrition and Health

Novel Technologies for Seaweed Polysaccharides Extraction and Their Use in Food with Therapeutically Applications—A Review

Bioactive Peptides from Marine Organisms

Marine Polysaccharides from Algae with Potential Biomedical Applications

From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds

Seaweed sulfated polysaccharides and their medicinal properties

Physiological and Clinical Aspects of Bioactive Peptides from Marine Animals

Novel Bioactive Compounds From Marine Sources as a Tool for Functional Food Development

Potential Benefits of Bioactive Compounds from Seaweed Extracts: Their Prospects and Pharmacological Promises